Individuals with hematologic malignancies enroll in hospice care less than patients with other cancers, and lack of access to blood transfusions is likely a key reason why.New survey data indicate ...

Lenalidomide (Revlimid)-induced second primary malignancies appear to be limited to patients with multiple myeloma, according to a systematic review and meta-analysis. While there was no significant ...

or on the link below. The field of malignant hematology is transforming with novel immunotherapeutic approaches. Unfortunately, quality of life, treatment efficacy, and life expectancy are negatively ...

young girl going into CT scanner Researchers estimate that, for every 10,000 children who undergo a CT scan today, 1.4 will develop a hematologic malignancy in the next 12 years. Undergoing computed ...

Here are the top 5 articles detailing the advancements in hematologic oncology from 2025. BTK inhibitors have revolutionized ...

HealthDay News — Among women presenting with a chief complaint of abnormal uterine bleeding (AUB), there is an estimated incidence of hematologic cancer of 3.6 cases per 1,000 women, according to ...

Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...

SEATTLE — April 30, 2018 — The clinic is staffed by a hematologist, medical geneticist, genetic counselor, and a hematology nurse. SCCA is one of only a few cancer centers in the nation to offer this ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...

In this interview, Ann S. LaCasce, MD, highlights a late-breaking abstract on in vivo CAR T-cell therapy use in multiple myeloma, as presented at ASH 2025.

Eosinophilic dermatosis in the context of haematologic malignancies is an uncommon but clinically significant cutaneous disorder. Characterised by an infiltration of eosinophils into the skin, it ...